Company intelligence / Profile preview

Naprod Life Sciences

Mumbai / Palghar, Maharashtra, Indianaprodgroup.com ↗

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Naprod Life Sciences operates at commercial scale with EU-GMP/WHO-GMP approved facilities. The company supplies oncology and anesthesia medicines globally. It has backward integration for APIs via its sister concern Mac-Chem Products. Its pipeline consists of new molecules added annually to maintain competitiveness in global markets. No clinical trial results are published as it primarily manufactures generics/specialty formulations rather than novel NCEs or biologics.

Therapeutic areas: Infectious DiseasesHematologyOncologyOther
Modalities: Small moleculeLiposomal formulationLyophilized injectableOral solid dosage forms (tablets/capsules)Liquid injectable
Industry: Biotech

Partnerships

Collaborates with various partners for R&D and contract manufacturing; no specific major pharma partnerships publicly named.

Beyond the preview

Go deeper on Naprod Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Naprod Life Sciences.

Explore the full profile